Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance.
about
Only slight impact of predicted replicative capacity for therapy response predictionComparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over timeSignificantly improved HIV inhibitor efficacy prediction employing proteochemometric models generated from antivirogram dataThe individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patientsPrevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failureStandardized representation, visualization and searchable repository of antiretroviral treatment-change episodesGenotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection.Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.Clinical evaluation of the potential utility of computational modeling as an HIV treatment selection tool by physicians with considerable HIV experiencePredictive value of HIV-1 genotypic resistance test interpretation algorithms.Maraviroc observational study: the impact of expanded resistance testing and clinical considerations for antiretroviral regimen selection in treatment-experienced patientsHIV Drug-Resistant Patient Information Management, Analysis, and Interpretation.Web resources for HIV type 1 genotypic-resistance test interpretation.A phylogenetic and Markov model approach for the reconstruction of mutational pathways of drug resistance.Antiretroviral genotypic resistance mutations in HIV-1 infected Korean patients with virologic failureThe use of computational models to predict response to HIV therapy for clinical cases in RomaniaPerformance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.From base pair to bedside: molecular simulation and the translation of genomics to personalized medicine.Ensemble Classifiers for Predicting HIV-1 Resistance from Three Rule-Based Genotypic Resistance Interpretation Systems.Resistance costs and future drug options of antiretroviral therapies: analysis of the role of NRTIs, NNRTIs, and PIs in a large clinical cohort.Use of the l1 norm for selection of sparse parameter sets that accurately predict drug response phenotype from viral genetic sequences.DR_SEQAN: a PC/Windows-based software to evaluate drug resistance using human immunodeficiency virus type 1 genotypes.Retrospective analysis of antiretroviral HIV treatment success based on medical history or guided by the reverse hybridisation LiPA HIV genotyping system.Evolution of genotypic resistance algorithms and their impact on the interpretation of clinical trials: an OPTIMA trial substudy.Genotypic resistance to lopinavir and fosamprenavir with or without ritonavir of clinical isolates from patients failing protease inhibitors-containing HAART regimens: prevalence and predictors.Prediction of Virologic Outcome of Salvage Antiretroviral Treatment by Different Systems for Interpreting Genotypic HIV Drug Resistance.Kommerzielle Systeme zur Genotypisierung von humanen Immundefizienzviren Typ 1: Vergleich von ViroSeq (Abbott) und TruGene (Bayer). Commercially available assays for genotyping of human immunodeficiency virus type 1: Comparison of ViroSeq (Abbott) an
P2860
Q28472749-43866147-7634-466C-9098-5115D3801B40Q28474806-CB4A4860-02F8-456C-9618-10D197F19955Q28486299-E0A0E2BB-0AF1-46A8-A64E-9EA5C9F743EDQ28536153-DB8B794E-9681-4749-98F4-7EDA7353DDE6Q28539186-E1F24A8D-0F07-4237-9CB8-680D687EC478Q28727940-340051B8-0F99-42CE-BA15-9362B01AC7C9Q34084316-C1763826-3642-4543-9A94-F6A2A1413AB1Q34352000-1B38F7B9-BF60-451D-8CBD-2404CFE69E26Q34539475-5741B139-D630-40E3-9A3B-BAE48659098BQ36641563-C4B1B163-724F-41B2-900C-939CB5246D7FQ36715890-81C68CF8-6B96-4817-9D5B-3955610F469CQ36765273-3CA19A1A-C9CB-4E1D-888C-2A2AB6CCFA78Q36899999-EE54ADCE-088F-4B1C-A22F-65567C101939Q37364205-AB806A05-CB00-4933-B733-E86B8FC07159Q37417912-6CACAE04-3852-410E-8861-67F5D95E9D01Q37441529-8D635415-FA30-426D-AF11-B56FFEC647F9Q37668850-20F051E0-CA60-4410-A621-99CE936DA89EQ38035239-04969C1F-0A14-44A1-B1EB-DB7AA69A12B0Q38600999-44508DDB-34B8-40D6-8010-DFA38ACD3FEDQ40223246-AA917D0B-9815-43A5-8785-FC340127CB26Q43105557-135E5332-A125-4221-B742-671E5B64DA43Q43257021-3B66FEBB-2188-4880-AF7A-9BBBF9F1E4B6Q47660926-3E62B4F4-C078-47F3-8105-1F4197F2152BQ51902460-34BCBAB3-6B77-4FFA-B7B3-5B2AFA3DECC7Q51907858-70289BB5-8E47-441A-8E45-9E18B445E945Q51913502-65D3EBEE-9097-43B1-A4E7-327BD51229DAQ57083225-41B10FC7-762D-44E9-8B2A-8EBB376648D9
P2860
Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Variable prediction of antiret ...... virus type 1 drug resistance.
@en
type
label
Variable prediction of antiret ...... virus type 1 drug resistance.
@en
prefLabel
Variable prediction of antiret ...... virus type 1 drug resistance.
@en
P2093
P50
P356
P1476
Variable prediction of antiret ...... virus type 1 drug resistance.
@en
P2093
Francesco Baldini
Maria Gabriella Rizzo
Maria Paola Trotta
Pasquale Narciso
Rita Murri
P304
P356
10.1086/375355
P407
P50
P577
2003-05-22T00:00:00Z